Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

ARCT

Arcturus Therapeutics (ARCT)

Arcturus Therapeutics Holdings Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ARCT
FechaHoraFuenteTítuloSímboloCompañía
10/08/202015:01GlobeNewswire Inc.Arcturus Therapeutics Announces Second Quarter 2020 Financial Results and Provides a Corporate UpdateNASDAQ:ARCTArcturus Therapeutics Holdings Inc
06/08/202007:30GlobeNewswire Inc.Arcturus Therapeutics Appoints Lance Kurata as Chief Legal OfficerNASDAQ:ARCTArcturus Therapeutics Holdings Inc
05/08/202005:10Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ARCTArcturus Therapeutics Holdings Inc
04/08/202007:30GlobeNewswire Inc.Arcturus Therapeutics to Report Second Quarter 2020 Financial Results and Provide Corporate Update on August 10, 2020NASDAQ:ARCTArcturus Therapeutics Holdings Inc
31/07/202015:01GlobeNewswire Inc.Arcturus Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional...NASDAQ:ARCTArcturus Therapeutics Holdings Inc
30/07/202005:10Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ARCTArcturus Therapeutics Holdings Inc
29/07/202005:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARCTArcturus Therapeutics Holdings Inc
28/07/202023:30GlobeNewswire Inc.Arcturus Therapeutics Announces Pricing of $173.0 Million Public Offering of Common StockNASDAQ:ARCTArcturus Therapeutics Holdings Inc
28/07/202015:01GlobeNewswire Inc.Arcturus Therapeutics Announces Proposed Public Offering of Common StockNASDAQ:ARCTArcturus Therapeutics Holdings Inc
23/07/202015:01GlobeNewswire Inc.Arcturus Therapeutics Announces Agreement with Israeli Ministry of Health to Supply COVID-19 Vaccine Candidate, LUNAR-COV19NASDAQ:ARCTArcturus Therapeutics Holdings Inc
21/07/202007:30GlobeNewswire Inc.Arcturus Therapeutics & Duke-NUS Received Approval to Proceed with Phase 1/2 Clinical Trial for COVID-19 Vaccine Candidate, L...NASDAQ:ARCTArcturus Therapeutics Holdings Inc
08/07/202005:10Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ARCTArcturus Therapeutics Holdings Inc
01/07/202007:00GlobeNewswire Inc.Arcturus Therapeutics Announces the Formation of its Vaccine Platform Scientific Advisory BoardNASDAQ:ARCTArcturus Therapeutics Holdings Inc
29/06/202007:00GlobeNewswire Inc.Arcturus Therapeutics to be Added to Russell 2000® IndexNASDAQ:ARCTArcturus Therapeutics Holdings Inc
12/06/202017:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARCTArcturus Therapeutics Holdings Inc
11/06/202007:00GlobeNewswire Inc.Arcturus Therapeutics to Present at the Raymond James Human Health Innovation Virtual ConferenceNASDAQ:ARCTArcturus Therapeutics Holdings Inc
05/06/202007:00GlobeNewswire Inc.Arcturus Therapeutics Announces First Healthy Volunteer Dosed in Phase 1 Study of ARCT-810 for Ornithine Transcarbamylase (OT...NASDAQ:ARCTArcturus Therapeutics Holdings Inc
22/05/202016:21Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ARCTArcturus Therapeutics Holdings Inc
22/05/202016:17Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:ARCTArcturus Therapeutics Holdings Inc
21/05/202007:30GlobeNewswire Inc.Ultragenyx Announces Exercise of Option to Purchase Additional Stock of Arcturus TherapeuticsNASDAQ:ARCTArcturus Therapeutics Holdings Inc
08/05/202016:24Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ARCTArcturus Therapeutics Holdings Inc
08/05/202016:00Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ARCTArcturus Therapeutics Holdings Inc
08/05/202008:30GlobeNewswire Inc.Arcturus Reports Additional Supportive Preclinical Data for its COVID-19 Vaccine Candidate (LUNAR-COV19)NASDAQ:ARCTArcturus Therapeutics Holdings Inc
07/05/202015:01GlobeNewswire Inc.Arcturus Therapeutics Announces First Quarter 2020 Financial Results and Provides a Corporate UpdateNASDAQ:ARCTArcturus Therapeutics Holdings Inc
04/05/202014:00GlobeNewswire Inc.Arcturus Therapeutics to Report First Quarter 2020 Financial Results and Provide a Corporate Update on May 7, 2020NASDAQ:ARCTArcturus Therapeutics Holdings Inc
04/05/202007:39GlobeNewswire Inc.Arcturus Therapeutics and Catalent Announce Partnership to Manufacture mRNA-Based COVID-19 VaccineNASDAQ:ARCTArcturus Therapeutics Holdings Inc
29/04/202015:47Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ARCTArcturus Therapeutics Holdings Inc
27/04/202015:06Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ARCTArcturus Therapeutics Holdings Inc
27/04/202006:00GlobeNewswire Inc.Arcturus Reports Positive Preclinical Data for its COVID-19 Vaccine CandidateNASDAQ:ARCTArcturus Therapeutics Holdings Inc
16/04/202008:10GlobeNewswire Inc.Arcturus Therapeutics Announces Pricing of $70.0 Million Public Offering of Common StockNASDAQ:ARCTArcturus Therapeutics Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:ARCT